Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Issue Archive
Events
MM&M Awards 2012
Webcasts
MM&M Virtual Summit
Whitepapers
Directories
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
> Features
Latest Features
MM&M Awards: The Hunt for Red October
James Chase
February 01, 2012
The MM&M Awards 2012 program is open for business.
Managed Care: Preferential Treatment
Elizabeth Jeffords February 01, 2012
Pharma firms are partnering with managed care companies to find drug evidence and improve outcomes. Can this strategy provide the proof payers demand before giving products preferential treatment?
Medical Advertising Hall of Fame: Lasting Legends
February 01, 2012
The Medical Advertising Hall of Fame's three new members have had exceptional lives and careers. We look back at their achievements
MM&M Therapeutic Focus: Cardiovascular
Noah Pines February 01, 2012
New cardiovascular treatments are gaining FDA approval as massive brands lose patent protection. Noah Pines on the potential of these new entrants to replace that lost revenue
Patient Education: Vying for Attention
Marc Iskowitz
February 01, 2012
Marc Iskowitz on how Shire's disease-awareness campaign engaged untreated Gen Y-ers, and why it's time for more patient-education efforts like it. Plus: See patient advocates discuss the ADHD market
Cradle of a Crisis
Noah Pines January 01, 2012
Makena, KV Pharma's drug for preventing preterm birth, has been no bundle of joy. In an exclusive interview, Noah Pines finds how the firm has navigated its difficulties and started to rebuild trust
All-Star Media Brand of the Year: Medical Economics
Tanya Lewis January 01, 2012
Media Brand of the Year: Medical Economics. From left: EVP, chief administrative officer Tom Ehardt, and EVP Georgiann Decenzo
All-Star Small Marketing Team of the Year: Incivek, Vertex
Marc Iskowitz
January 01, 2012
Small Pharma Marketing Team of the Year: Incivek. From left: Pamela Stephenson, VP of marketing in charge of Incivek brand; Paul Daruwala, VP of marketing/HCV franchise, Vertex Pharmaceuticals
All-Star Large Marketing Team of the Year: Victoza, Novo Nordisk
James Chase
January 01, 2012
Large Pharma Marketing Team of the Year: Victoza. From left: John Spera, brand director, Victoza PCP marketing; Will Bainbridge, VP, Victoza brand; and Jeff Fayer, brand director, Victoza patient marketing
All-Star Agency of the Year: ICC Lowe
Marc Iskowitz
January 01, 2012
Agency/Network of the Year: ICC Lowe. From left: Steve Viviano, CEO; Chet Moss, chief creative officer; Paul O'Neil, president, ICC Lowe
All-Star Company of the Year: Boehringer Ingelheim
Matthew Arnold
January 01, 2012
Company of the Year: Boehringer Ingelheim. From left: President/CEO Greg Behar; David Pass, VP, US pipeline marketing; and Kathleen Dowd, VP, respiratory marketing
Leadership Exchange: Multichannel Marketing
James Chase
December 01, 2011
Choosing channels and creating an integrated campaign isn't easy, but our panel of experts can help. James Chase directs the discussion
Pipeline 2012: Pharma's Front-Runners
Marc Iskowitz
December 01, 2011
Profiling a dozen agents on deck plus many products in the wings, MM&M's Pipeline 2012 sees a year of change.
Pharma Marketing Outlook 2012: Anderson's 360
Noah Pines December 01, 2011
Sanford Bernstein's Tim Anderson, MD, who has taken Institutional Investor's top ranking three years running, on what 2012 has in store
Pharma Marketing Outlook 2012: Detailing D.C.
Matthew Arnold
December 01, 2011
To stave off federal budget cuts, the drug industry needs to show politicians its worth as a vital source of jobs, treatments and innovation
What agencies and clients want
James Chase
, Marc Iskowitz November 01, 2011
As pressure mounts on the industry, it's more important to make the agency-client relationship work. James Chase and Marc Iskowitz ask agency leaders and pharma marketers what they want from each other
Pharma Sales Report: Special Force
Marc Iskowitz
November 01, 2011
Seeking part of the primary care market, specialty and biotech firms are filling the void being left by Big Pharma. Marc Iskowitz on the strategies and tactics for engaging customers and maximizing sales budgets
700 Stars: The MM&M Awards 2011
James Chase
November 01, 2011
Almost 700 of the industry's brightest stars came to New York's Cipriani 42nd Street for the sold-out MM&M Awards 2011 dinner and ceremony.
The MM&M Awards 2011 Judges
October 13, 2011
This summer, a highly regarded group of 40 of the industry's biggest doers, thinkers and opinion makers used their combined expertise to review and score several hundred entries for the MM&M Awards 2011
Best Total Integration Program for Large Companies
October 13, 2011
Recognizes and rewards the best use of different media for a single campaign for maximum measurable effect for clients companies with $10 billion or more in 2010 worldwide revenue.
more »
Agency Spotlight
Click here for MM&M’s guide to Healthcare Agencies
Subscribe to the RSS for this page [
view all our RSS feeds here
]
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MM&M Awards Photos
Most Popular
Most Emailed
Most Recent
Elsevier begins outreach as push-back on publisher threatens to widen
Bydureon approval a shot across bow for Victoza
Jobson Medical files for chapter 11 debt relief
Patient Education: Vying for Attention
P&G signals plans to cut ad costs by shifting to digital media
FDA study casts doubt on danger of "distracting visuals"
Generics makers approach a cliff of their own
MM&M Therapeutic Focus: Cardiovascular
AstraZeneca announces more layoffs, Q4 results
Komen, caught up in the culture wars, nurses damaged brand
Jobson Medical files for chapter 11 debt relief
Elsevier begins outreach as push-back on publisher threatens to widen
P&G signals plans to cut ad costs by shifting to digital media
Bydureon approval a shot across bow for Victoza
Generics makers approach a cliff of their own
FDA study casts doubt on danger of "distracting visuals"
Industry group releases digital best practices
Merck results buoyed by sales of Januvia franchise
Allergan scrubs some doc-payment data, spares med-ed grants
MM&M Therapeutic Focus: Cardiovascular
Industry group releases digital best practices
Merck, GSK shrug off rec to make HPV vaccine routine
Komen, caught up in the culture wars, nurses damaged brand
Allergan scrubs some doc-payment data, spares med-ed grants
Jobson Medical files for chapter 11 debt relief
A new test to identify Down Syndrome
Making a political football out of Plan B
Med Ed Report briefs
Merck results buoyed by sales of Januvia franchise
AstraZeneca announces more layoffs, Q4 results
Popular Topics
Adherence
Advertising
Approval
Brand
CME
Companion Diagnostics
Corporate Reputation
DDMAC
Digital
Direct To Consumer (DTC)
DTC
Earnings
Facebook
FDA
Financial
Generic
Guidance
Launch
Loyalty Program
Magazine
Major Statement
Media
Regulatory
Social Media
Television